Search

Search Constraints

You searched for: Author/Creator Seridi, Loqmane

Search Results

1. 251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus. (April 2019)

3. First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial. (October 2020)

4. Hologenome analysis of two marine sponges with different microbiomes. (December 2016)

5. Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition. (April 2021)

6. O9 Reduction of interferon-γ and elevated baseline cytotoxic gene expression in the blood associate with ustekinumab response in SLE. (23rd March 2020)

7. OP0278 BIOMARKER PROFILING REVEALS NOVEL MECHANISTIC INSIGHTS INTO USTEKINUMAB THERAPEUTIC RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019)

8. Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus. Issue 11 (7th July 2022)

10. Specificity and transcriptional activity of microbiota associated with low and high microbial abundance sponges from the Red Sea. Issue 6 (20th August 2013)